Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity

  • The PLOS ONE Staff

Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity

  • The PLOS ONE Staff
PLOS
x

Several of the grant numbers in the Funding section are listed incorrectly. The correct funding information is as follows: This research was supported by the Ministry of Science and Technology of China (2015CB964502, 2014CB964802), the National Natural Science Foundation of China (31371419), Science and Technology Commission of Shanghai Municipality (14DZ1900402). The publisher apologizes for the errors.

Reference

  1. 1. Lu J, Cui J, Li X, Wang X, Zhou Y, Yang W, et al. (2016) An Anti-Parkinson’s Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity. PLoS ONE 11(11): e0166415. pmid:27835671